These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 31481130)
21. Early-in-life neuroanatomical and behavioural trajectories in a triple transgenic model of Alzheimer's disease. Kong V; Devenyi GA; Gallino D; Ayranci G; Germann J; Rollins C; Chakravarty MM Brain Struct Funct; 2018 Sep; 223(7):3365-3382. PubMed ID: 29948190 [TBL] [Abstract][Full Text] [Related]
22. In Vivo Detection of Gray Matter Neuropathology in the 3xTg Mouse Model of Alzheimer's Disease with Diffusion Tensor Imaging. Snow WM; Dale R; O'Brien-Moran Z; Buist R; Peirson D; Martin M; Albensi BC J Alzheimers Dis; 2017; 58(3):841-853. PubMed ID: 28505976 [TBL] [Abstract][Full Text] [Related]
25. Evidence of intraneuronal Aβ accumulation preceding tau pathology in the entorhinal cortex. Welikovitch LA; Do Carmo S; Maglóczky Z; Szocsics P; Lőke J; Freund T; Cuello AC Acta Neuropathol; 2018 Dec; 136(6):901-917. PubMed ID: 30362029 [TBL] [Abstract][Full Text] [Related]
26. [Alzheimer disease: cellular and molecular aspects]. Octave JN Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248 [TBL] [Abstract][Full Text] [Related]
27. Plasma Tau Association with Brain Atrophy in Mild Cognitive Impairment and Alzheimer's Disease. Deters KD; Risacher SL; Kim S; Nho K; West JD; Blennow K; Zetterberg H; Shaw LM; Trojanowski JQ; Weiner MW; Saykin AJ; J Alzheimers Dis; 2017; 58(4):1245-1254. PubMed ID: 28550246 [TBL] [Abstract][Full Text] [Related]
28. Molecular imaging of dementia. Mori T; Maeda J; Shimada H; Higuchi M; Shinotoh H; Ueno S; Suhara T Psychogeriatrics; 2012 Jun; 12(2):106-14. PubMed ID: 22712644 [TBL] [Abstract][Full Text] [Related]
29. Quantitative analysis of tau protein-immunoreactive accumulations and beta amyloid protein deposits in the cerebral cortex of the mouse lemur, Microcebus murinus. Giannakopoulos P; Silhol S; Jallageas V; Mallet J; Bons N; Bouras C; Delaère P Acta Neuropathol; 1997 Aug; 94(2):131-9. PubMed ID: 9255387 [TBL] [Abstract][Full Text] [Related]
30. Tauopathy contributes to synaptic and cognitive deficits in a murine model for Alzheimer's disease. Stancu IC; Ris L; Vasconcelos B; Marinangeli C; Goeminne L; Laporte V; Haylani LE; Couturier J; Schakman O; Gailly P; Pierrot N; Kienlen-Campard P; Octave JN; Dewachter I FASEB J; 2014 Jun; 28(6):2620-31. PubMed ID: 24604080 [TBL] [Abstract][Full Text] [Related]
31. Comparative pathobiology of β-amyloid and the unique susceptibility of humans to Alzheimer's disease. Rosen RF; Tomidokoro Y; Farberg AS; Dooyema J; Ciliax B; Preuss TM; Neubert TA; Ghiso JA; LeVine H; Walker LC Neurobiol Aging; 2016 Aug; 44():185-196. PubMed ID: 27318146 [TBL] [Abstract][Full Text] [Related]
32. An Intracellular Amyloid-β/AβPP Epitope Correlates with Neurodegeneration in those Neuronal Populations Early Involved in Alzheimer's Disease. Esquerda-Canals G; Martí-Clúa J; Roda AR; Villegas S J Alzheimers Dis; 2017; 59(3):1079-1096. PubMed ID: 28697564 [TBL] [Abstract][Full Text] [Related]
33. Dogs with Cognitive Dysfunction as a Spontaneous Model for Early Alzheimer's Disease: A Translational Study of Neuropathological and Inflammatory Markers. Schütt T; Helboe L; Pedersen LØ; Waldemar G; Berendt M; Pedersen JT J Alzheimers Dis; 2016 Mar; 52(2):433-49. PubMed ID: 27003213 [TBL] [Abstract][Full Text] [Related]
34. Associations between quantitative [ Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512 [TBL] [Abstract][Full Text] [Related]
35. [Does Alzheimer's disease exist in all primates? Alzheimer pathology in non-human primates and its pathophysiological implications (I)]. Toledano A; Alvarez MI; López-Rodríguez AB; Toledano-Díaz A; Fernández-Verdecia CI Neurologia; 2012; 27(6):354-69. PubMed ID: 22197064 [TBL] [Abstract][Full Text] [Related]
36. Alzheimer's disease pathological lesions activate the spleen tyrosine kinase. Schweig JE; Yao H; Beaulieu-Abdelahad D; Ait-Ghezala G; Mouzon B; Crawford F; Mullan M; Paris D Acta Neuropathol Commun; 2017 Sep; 5(1):69. PubMed ID: 28877763 [TBL] [Abstract][Full Text] [Related]
37. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy. Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833 [TBL] [Abstract][Full Text] [Related]
38. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease. Kuznetsova E; Schliebs R Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514 [TBL] [Abstract][Full Text] [Related]
39. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD? Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742 [TBL] [Abstract][Full Text] [Related]
40. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology. Isopi E; Granzotto A; Corona C; Bomba M; Ciavardelli D; Curcio M; Canzoniero LM; Navarra R; Lattanzio R; Piantelli M; Sensi SL Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]